Beximco Pharmaceuticals Limited Sponsored GDR RegS Balance Sheet
Beximco Pharmaceuticals Limited Sponsored GDR RegS's total assets for Q2 2023 were $69.31B, an increase of 2.73% from the previous quarter. GB:BXP total liabilities were $23.59B for the fiscal quarter, a 10.09% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.